| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | MediciNova Inc expected to post a loss of 5 cents a share - Earnings Preview | 1 | Reuters | ||
| Di | MediciNova, Inc.: MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast) | 46 | GlobeNewswire (Europe) | LA JOLLA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| 03.04. | MediciNova, Inc.: MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) | 69 | GlobeNewswire (Europe) | LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| 01.04. | MEDICINOVA INC - 8-K, Current Report | 1 | SEC Filings | ||
| 27.03. | MediciNova, Inc.: MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan | 134 | GlobeNewswire (Europe) | LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| 21.03. | MediciNova, Inc.: MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society | 52 | GlobeNewswire (Europe) | LA JOLLA, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| 12.03. | MediciNova, Inc.: MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology | 108 | GlobeNewswire (Europe) | LA JOLLA, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| 15.02. | MEDICINOVA INC - 10-K, Annual Report | 2 | SEC Filings | ||
| 13.02. | MediciNova Inc expected to post a loss of 8 cents a share - Earnings Preview | 3 | Reuters | ||
| 17.01. | MediciNova, Inc.: MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China | 258 | GlobeNewswire (Europe) | LA JOLLA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| 22.12.23 | MediciNova, Inc.: MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of Toxicology | 158 | GlobeNewswire (Europe) | LA JOLLA, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| 07.12.23 | MediciNova, Inc.: MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe | 3 | GlobeNewswire (USA) | ||
| 20.11.23 | MediciNova, Inc.: MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology | 190 | GlobeNewswire (Europe) | LA JOLLA, Calif., Nov. 19, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.979 |
| NEL | 1.870 |
| SIEMENS ENERGY | 1.648 |
| TUI | 1.284 |
| MERCEDES-BENZ | 1.281 |
| BAYER | 1.242 |
| PALANTIR TECHNOLOGIES | 1.190 |
| NVIDIA | 927 |
| ALLIANZ | 920 |
| DEUTSCHE BANK | 919 |
| DEUTSCHE LUFTHANSA | 882 |
| BYD | 844 |
| PLUG POWER | 810 |
| BORUSSIA DORTMUND | 776 |
| INFINEON | 742 |
| PUMA | 740 |
| VARTA | 732 |
| SMA SOLAR | 687 |
| RWE | 636 |
| FRESENIUS | 635 |
| VOLKSWAGEN | 628 |
| TESLA | 624 |
| RHEINMETALL | 613 |
| AIXTRON SE | 611 |
| RENK GROUP | 593 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
